From the first report of a BRAF mutation in non-small-cell lung cancer (NSCLC) in 2011 [28], variable mutation frequencies have been reported ranging from 1.5–3.5% to 7–8% [34,71,72,73]. Here, BRAF is linked to non-small cell lung carcinoma.